John Lam

1.2k total citations
24 papers, 949 citations indexed

About

John Lam is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, John Lam has authored 24 papers receiving a total of 949 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 13 papers in Genetics and 12 papers in Molecular Biology. Recurrent topics in John Lam's work include Virus-based gene therapy research (13 papers), CAR-T cell therapy research (9 papers) and Viral Infectious Diseases and Gene Expression in Insects (7 papers). John Lam is often cited by papers focused on Virus-based gene therapy research (13 papers), CAR-T cell therapy research (9 papers) and Viral Infectious Diseases and Gene Expression in Insects (7 papers). John Lam collaborates with scholars based in United States, Finland and Japan. John Lam's co-authors include David T. Curiel, Ronald D. Alvarez, Anna Kanerva, Akseli Hemminki, Mack N. Barnes, Gerd Bauerschmitz, Victor Krasnykh, Minghui Wang, Galina Mikheeva and Gene P. Siegal and has published in prestigious journals such as Journal of Virology, Clinical Cancer Research and Molecular Therapy.

In The Last Decade

John Lam

22 papers receiving 931 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Lam United States 13 808 634 582 159 93 24 949
Julia Davydova United States 22 833 1.0× 663 1.0× 596 1.0× 291 1.8× 110 1.2× 66 1.2k
Ronald G. Crystal United States 7 561 0.7× 576 0.9× 234 0.4× 79 0.5× 135 1.5× 9 846
Timo Joensuu Finland 18 716 0.9× 367 0.6× 668 1.1× 176 1.1× 118 1.3× 27 893
Minna Oksanen Finland 17 726 0.9× 367 0.6× 666 1.1× 187 1.2× 113 1.2× 24 884
J. Ironside United Kingdom 4 708 0.9× 583 0.9× 538 0.9× 180 1.1× 85 0.9× 7 916
Assia L. Angelova Germany 14 582 0.7× 250 0.4× 440 0.8× 104 0.7× 224 2.4× 34 733
Arnold Kloos Germany 14 276 0.3× 220 0.3× 408 0.7× 65 0.4× 47 0.5× 27 630
J. Andrea McCart Canada 15 759 0.9× 343 0.5× 608 1.0× 188 1.2× 131 1.4× 22 1.1k
Pin-Yi Wang United States 14 327 0.4× 258 0.4× 331 0.6× 48 0.3× 40 0.4× 32 792
Kevin G. Shim United States 13 318 0.4× 219 0.3× 374 0.6× 66 0.4× 55 0.6× 28 634

Countries citing papers authored by John Lam

Since Specialization
Citations

This map shows the geographic impact of John Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Lam more than expected).

Fields of papers citing papers by John Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Lam. The network helps show where John Lam may publish in the future.

Co-authorship network of co-authors of John Lam

This figure shows the co-authorship network connecting the top 25 collaborators of John Lam. A scholar is included among the top collaborators of John Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Lam. John Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lam, John, et al.. (2020). A Practical Approach to Diagnosis of B-Cell Lymphomas With Diffuse Large Cell Morphology. Archives of Pathology & Laboratory Medicine. 144(2). 160–167. 12 indexed citations
3.
Lam, John, et al.. (2020). Two cases of rare subglottic MALT lymphoma of the larynx. American Journal of Otolaryngology. 41(6). 102736–102736. 4 indexed citations
4.
Lam, John, et al.. (2019). Uterine intravascular large B-cell lymphoma presenting as abnormal uterine bleeding. European Journal of Gynaecological Oncology. 40(3). 490–493. 1 indexed citations
6.
Lam, John, Akseli Hemminki, Anna Kanerva, et al.. (2007). A three-dimensional assay for measurement of viral-induced oncolysis. Cancer Gene Therapy. 14(4). 421–430. 13 indexed citations
7.
Cruse, Julius M., et al.. (2007). Diminished CD10, CD13, and CD15 expression in a differentiated granulocyte population in CML. Experimental and Molecular Pathology. 83(2). 274–276. 2 indexed citations
8.
Cruse, Julius M., et al.. (2006). Antigenic transformation in plasma cell dyscrasia. Experimental and Molecular Pathology. 81(2). 157–161. 1 indexed citations
9.
Cruse, Julius M., et al.. (2005). Aberrant expression of CD7, CD56, and CD79a antigens in acute myeloid leukemias. Experimental and Molecular Pathology. 79(1). 39–41. 35 indexed citations
10.
Lewis, Robert E., et al.. (2005). Surface and cytoplasmic immunoglobulin expression in B-cell chronic lymphocytic leukemia (CLL). Experimental and Molecular Pathology. 79(2). 146–150. 12 indexed citations
11.
Wu, Hongju, Tian Han, John Lam, et al.. (2004). Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapy. Gene Therapy. 11(10). 874–878. 34 indexed citations
12.
Lam, John, Anna Kanerva, Gerd Bauerschmitz, et al.. (2004). 108 Evaluation of Five Conditionally Replicative Adenoviruses for Ovarian Cancer Therapy. International Journal of Gynecological Cancer. 14. 32–33.
13.
Lam, John, Anna Kanerva, Gerd Bauerschmitz, et al.. (2004). Inter‐patient variation in efficacy of five oncolytic adenovirus candidates for ovarian cancer therapy. The Journal of Gene Medicine. 6(12). 1333–1342. 32 indexed citations
14.
Haviv, Yosef S., Koichi Takayama, Peter A. Nagi, et al.. (2003). Modulation of renal glomerular disease using remote delivery of adenoviral‐encoded solubletype II TGF‐β receptor fusion molecule. The Journal of Gene Medicine. 5(10). 839–851. 14 indexed citations
15.
Kanerva, Anna, Kurt R. Zinn, Tandra R. Chaudhuri, et al.. (2003). Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus. Molecular Therapy. 8(3). 449–458. 143 indexed citations
16.
Lam, John, Gerd Bauerschmitz, Anna Kanerva, et al.. (2003). Replication of an integrin targeted conditionally replicating adenovirus on primary ovarian cancer spheroids. Cancer Gene Therapy. 10(5). 377–387. 23 indexed citations
17.
Kawakami, Yosuke, Hui Li, John Lam, et al.. (2003). Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication.. PubMed. 63(6). 1262–9. 61 indexed citations
18.
Kanerva, Anna, Minghui Wang, Gerd Bauerschmitz, et al.. (2002). Gene Transfer to Ovarian Cancer Versus Normal Tissues with Fiber-Modified Adenoviruses. Molecular Therapy. 5(6). 695–704. 156 indexed citations
19.
Kanerva, Anna, Galina Mikheeva, Victor Krasnykh, et al.. (2002). Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells.. PubMed. 8(1). 275–80. 208 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026